Compare WVE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | BVS |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.7M | 982.2M |
| IPO Year | 2015 | 2016 |
| Metric | WVE | BVS |
|---|---|---|
| Price | $4.89 | $13.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $29.81 | $14.00 |
| AVG Volume (30 Days) | ★ 3.4M | 557.9K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.52 |
| Revenue | $3,704,000.00 | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | $85.67 | $7.06 |
| P/E Ratio | ★ N/A | $27.06 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $4.65 | $6.26 |
| 52 Week High | $21.73 | $15.89 |
| Indicator | WVE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 52.38 |
| Support Level | N/A | $13.44 |
| Resistance Level | $6.33 | $14.92 |
| Average True Range (ATR) | 0.23 | 0.45 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 22.03 | 28.38 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.